Disease Genomics & Genomics in Disease Pathogenesis

Genomics is the study of an organism's total or partial genetic or epigenetic sequence information, with the goal of understanding the structure and function of these sequences as well as downstream biological outputs. Genomics in health studies the genetic mechanisms at work in disease, as well as the interactions between this biological information and health interventions and environmental factors. Human genomics isn't the only branch of genomics that has implications for human health. Plants, vectors, and diseases are just a few of the organisms whose genomes interact with the human genome. It is predicted that genomic technology will continue to improve population health and well-being throughout their lives. Further genomic and associated phenotypic data are critical for improving our understanding of disease risk and pathogenesis, as well as providing improved healthcare. The advantages of genomic technology in healthcare extend beyond immediate improvements in diagnosis and treatment, where a diagnosis is the gateway to the best care, to contributions to a broader understanding of disease and health, as well as informing appropriately targeted public health initiatives.

For those with cancer and genetic disorders, genomic medicine offers a great possibility for faster, more precise diagnosis and individualized treatment. It is critical that all people have equal access to tests and treatment (s). Evidence-based medicine is at the heart of these advancements, and it's critical to include research and data collection into patient monitoring. Developments in genomics will necessitate major investment, such as more knowledgeable people and laboratories equipped with appropriate technology. Pathologists are at the centre of these advancements and, as a result of their extensive experience in tissue handling, processing, and reporting, they must be involved throughout the program.